Back to Practical Pharmacovigilance

Articles from Drug Safety

These pdfs have been provided by agreement with Wolters Kluwer Health / Adis, the copyright holder. Printing and storage of these pdfs is for scholarly research and educational and personal use only. Any copyright or other notices or disclaimers must not be removed, obscured or modified. The PDF may not be re-posted on any other website (including personal and university sites) without specific permission to do so being sought from the copyright holder. No commercial use of these pdfs is permitted.

• An ABC of drug-related problems Meyboom et al, 2000.
• Signal Selection and Follow-up in Pharmacovigilance. Meyboom et al, 2002.
• Data Quality Management in Pharmacovigilance. Lindquist, 2004.
• The Value of Reporting Therapeutic Ineffectiveness as an Adverse Drug Reaction. Meyboom et al, 2000.
• Use of Measures of Disproportionality in Pharmacovigilance; three Dutch examples. Egberts et al, 2002.
• Glucose intolerance with Atypical Antipsychotics. Hedenmalm et al, 2002.
• The Role of the WHO Programme on International Drug Monitoring in co-ordinating worldwide drug safety efforts. Olsson, 1998.
• A retrospective evaluation of a Data Mining Approach to aid finding new Adverse Drug Reaction Signals in the WHO International Database. Lindquist et al, 2000.
• A Data Mining Approach for Signal Detection and Analysis. Bate et al, 2002.
• Assessing the Impact of Drug safety Signals from the WHO Database presented in 'Signal'. Ståhl et al, 2003.
• From the Uppsala Monitoring Centre; a review of Viewpoint Part 1 and Part 2. Hugman, 2005.
• Labelling and Dear Doctor letters, are they non-committal? van Grootheest & Edwards, 2002.
• What are the real lessons from Vioxx®? Edwards, 2005.
• Pharmacovigilance in Perspective. Meyboom et al, 1999.
• The WHO World Alliance for Patient Safety. Edwards, 2005.
  

Articles from Drug Safety page last updated 18 April 2007